Erdem, G. U. Et Al. 2018. 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane. Bosnian Journal of Basic Medical Sciences , vol.18, no.2 , 170-177.

Erdem, G. U., Bozkaya, Y., Ozdemir, N. Y., DEMİRCİ, N. S., Yazici, O., & ZENGİN, N., (2018). 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane. Bosnian Journal of Basic Medical Sciences , vol.18, no.2, 170-177.

Erdem, Gokmen Et Al. "5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane," Bosnian Journal of Basic Medical Sciences , vol.18, no.2, 170-177, 2018

Erdem, Gokmen U. Et Al. "5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane." Bosnian Journal of Basic Medical Sciences , vol.18, no.2, pp.170-177, 2018

Erdem, G. U. Et Al. (2018) . "5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane." Bosnian Journal of Basic Medical Sciences , vol.18, no.2, pp.170-177.

@article{article, author={Gokmen Umut Erdem Et Al. }, title={5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane}, journal={Bosnian Journal of Basic Medical Sciences}, year=2018, pages={170-177} }